Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Tuberculosis

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 89 articles: HTML format Text format

Single Articles

October 2019
1. DUTTA NK, Bruiners N, Zimmerman MD, Tan S, et al
   Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice.
   J Infect Dis. 2019 Oct 12. pii: 5586531. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
2. NATHAVITHARANA RR, Yoon C, Macpherson P, Dowdy DW, et al
   Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests.
   J Infect Dis. 2019;220.
   PubMed     Text format     Abstract available
   
   
   
3. GEORGHIOU SB, Schumacher SG, Rodwell TC, Colman RE, et al
   Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.
   J Infect Dis. 2019;220.
   PubMed     Text format     Abstract available
   
   
   
4. DRAIN PK, Gardiner J, Hannah H, Broger T, et al
   Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose Tuberculosis.
   J Infect Dis. 2019;220.
   PubMed     Text format     Abstract available
   
   
   
5. SCHUMACHER SG, Wells WA, Nicol MP, Steingart KR, et al
   Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.
   J Infect Dis. 2019;220.
   PubMed     Text format     Abstract available
   
   
   
6. DENKINGER CM, Schumacher SG, Gilpin C, Korobitsyn A, et al
   Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles.
   J Infect Dis. 2019;220.
   PubMed     Text format     Abstract available
   
   
   August 2019
7. KATELARIS AL, Jackson C, Southern J, Gupta RK, et al
   Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort.
   J Infect Dis. 2019 Aug 29. pii: 5556484. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
8. RIOU C, Jhilmeet N, Rangaka MX, Wilkinson RJ, et al
   Tuberculosis antigen-specific T cell responses during the first 6 months of antiretroviral treatment.
   J Infect Dis. 2019 Aug 17. pii: 5550849. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
9. WU Q, Hossfeld A, Gerberick A, Saljoughian N, et al
   Mycobacterium tuberculosis enhances macrophage P-glycoprotein (MDR1) expression and activity to promote intracellular survival during anti-TB drug treatment.
   J Infect Dis. 2019 Aug 14. pii: 5549997. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   July 2019
10. VERRALL AJ, Alisjahbana B, Apriani L, Novianty N, et al
    Early Clearance of Mycobacterium tuberculosis: The INFECT Case Contact Cohort Study in Indonesia.
    J Infect Dis. 2019 Jul 12. pii: 5531576. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
11. LALVANI A, Seshadri C
    Understanding How BCG Vaccine Protects Against Mycobacterium tuberculosis Infection: Lessons From Household Contact Studies.
    J Infect Dis. 2019 Jul 12. pii: 5531579. doi: 10.1093.
    PubMed     Text format    
    
    
    June 2019
12. SHAH JA, Lindestam Arlehamn CS, Horne DJ, Sette A, et al
    Non-tuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.
    J Infect Dis. 2019 Jun 4. pii: 5511511. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2019
13. BLUMENTHAL MJ, Schutz C, Barr D, Locketz M, et al
    The contribution of KSHV to mortality in hospitalized HIV-infected patients being investigated for tuberculosis in South Africa.
    J Infect Dis. 2019 Apr 20. pii: 5475547. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
14. YANG D, He X, Li S, Liu J, et al
    Rv1075c of Mycobacterium tuberculosis is a GDSL-Like Esterase and is Important for Intracellular Survival.
    J Infect Dis. 2019 Apr 18. pii: 5475176. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
15. VERRALL AJ, Schneider M, Alisjahbana B, Apriani L, et al
    Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses.
    J Infect Dis. 2019 Apr 8. pii: 5431213. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2019
16. ELKINGTON P, Lerm M, Kapoor N, Mahon R, et al
    In Vitro Granuloma Models of Tuberculosis: Potential and Challenges.
    J Infect Dis. 2019 Mar 31. pii: 5423999. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
17. MOLIVA JI, Duncan MA, Olmo-Fontanez A, Akhter A, et al
    The lung mucosa environment in the elderly increases host susceptibility to Mycobacterium tuberculosis infection.
    J Infect Dis. 2019 Mar 29. pii: 5422213. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
18. TONBY K, Mortensen R, Ruhwald M, Dyrhol-Riise AM, et al
    KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment.
    J Infect Dis. 2019 Mar 19. pii: 5387565. doi: 10.1093.
    PubMed     Text format    
    
    
    
19. CANCINO-MUNOZ I, Moreno-Molina M, Furio V, Goig GA, et al
    Cryptic resistance mutations associated to misdiagnoses of Multidrug-resistant tuberculosis.
    J Infect Dis. 2019 Mar 15. pii: 5381710. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
20. DEY RJ, Dey B, Singh AK, Praharaj M, et al
    BCG overexpressing an endogenous STING agonist provides enhanced protection against pulmonary tuberculosis.
    J Infect Dis. 2019 Mar 15. pii: 5381716. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
21. TER BEEK L, Alffenaar JC, Bolhuis MS, van der Werf TS, et al
    Tuberculosis-related Malnutrition: Public Health Implications.
    J Infect Dis. 2019 Mar 5. pii: 5369706. doi: 10.1093.
    PubMed     Text format    
    
    
    February 2019
22. LACHMANDAS E, Eckold C, Bohme J, Koeken VACM, et al
    Metformin alters human host responses to Mycobacterium tuberculosis in healthy subjects.
    J Infect Dis. 2019 Feb 12. pii: 5316196. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
23. ADAMS KN, Verma AK, Gopalaswamy R, Adikesavalu H, et al
    Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance.
    J Infect Dis. 2019 Feb 7. pii: 5308873. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2018
24. DESHPANDE D, Pasipanodya JG, Srivastava S, Martin KR, et al
    Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis.
    J Infect Dis. 2018 Dec 28. pii: 5263980. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
25. FRANK DJ, Horne DJ, Dutta NK, Shaku MT, et al
    Remembering the Host in Tuberculosis Drug Development.
    J Infect Dis. 2018 Dec 21. pii: 5257354. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
26. KOEKEN VACM, Lachmandas E, Riza A, Matzaraki V, et al
    The role of glutamine metabolism for host defense against Mycobacterium tuberculosis infection.
    J Infect Dis. 2018 Dec 12. pii: 5239862. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    November 2018
27. SINHA P, Davis J, Saag L, Wanke C, et al
    Undernutrition and Tuberculosis: Public Health Implications.
    J Infect Dis. 2018 Nov 22. pii: 5197537. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
28. TOMASICCHIO M, Davids M, Pooran A, Theron G, et al
    The injectable contraceptive medroxyprogesterone acetate attenuates Mycobacterium tuberculosis-specific host immunity through the glucocorticoid receptor.
    J Infect Dis. 2018 Nov 19. pii: 5191220. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    October 2018
29. MAYITO J, Andia I, Belay M, Jolliffe DA, et al
    Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection.
    J Infect Dis. 2018 Oct 30. pii: 5146773. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
30. AMARAL EP, Machado de Salles E, Barbosa Bomfim CC, Salgado RM, et al
    Inhibiting Adenosine Receptor Signaling Promotes Accumulation of Effector CD4+ T Cells in the Lung Parenchyma During Severe Tuberculosis.
    J Infect Dis. 2018 Oct 11. pii: 5126506. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    September 2018
31. ARUMUGAM P, Shankaran D, Bothra A, Gandotra S, et al
    The MmpS6-MmpL6 operon is an oxidative stress response system providing selective advantage to Mycobacterium tuberculosis in stress.
    J Infect Dis. 2018 Sep 7. pii: 5092676. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    August 2018
32. SHIN SS, Modongo C, Baik Y, Allender C, et al
    Mixed infections are associated with poor treatment outcomes among newly diagnosed tuberculosis patients independent of pre-treatment heteroresistance.
    J Infect Dis. 2018 Aug 4. pii: 5066433. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    July 2018
33. GEBREMICAEL G, Kassa D, Quinten E, Alemayehu Y, et al
    Host gene expression kinetics during treatment of tuberculosis in HIV-coinfected individuals is independent of HAART therapy.
    J Infect Dis. 2018 Jul 2. pii: 5047436. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    June 2018
34. NELSON KN, Shah NS, Mathema B, Ismail N, et al
    Spatial Patterns of Extensively drug-resistant Tuberculosis (XDR-tuberculosis) transmission in KwaZulu-Natal, South Africa.
    J Infect Dis. 2018 Jun 28. pii: 5046349. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
35. ORDONEZ AA, Pokkali S, Sanchez-Bautista J, Klunk MH, et al
    Matrix Metalloproteinase Inhibition in a Murine Model of Cavitary Tuberculosis Paradoxically Worsens Pathology.
    J Infect Dis. 2018 Jun 16. pii: 5039594. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    May 2018
36. MAHLA RS
    KLRG1 Signaling is Contextual to Tuberculosis Immunity.
    J Infect Dis. 2018 May 28. pii: 5017236. doi: 10.1093.
    PubMed     Text format    
    
    
    
37. REICHLER MR, Khan A, Sterling TR, Zhao H, et al
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis. 2018 May 15. pii: 4996045. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
38. GUTHRIE JL, Delli Pizzi A, Roth D, Kong C, et al
    Genotyping and Whole Genome Sequencing to Identify Tuberculosis Transmission to Pediatric Patients in British Columbia, Canada, 2005-2014.
    J Infect Dis. 2018 May 11. pii: 4995040. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2018
39. MILLER AC, Livchits V, Ahmad Khan F, Atwood S, et al
    Turning off the tap: Using the FAST approach to stop the spread of drug-resistant tuberculosis in Russian Federation.
    J Infect Dis. 2018 Apr 5. pii: 4961495. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
40. LACHMANDAS E, Rios-Miguel AB, Koeken VACM, van der Pasch E, et al
    Tissue metabolic changes drive cytokine responses to Mycobacterium tuberculosis.
    J Infect Dis. 2018 Apr 3. pii: 4959339. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2018
41. URBANOWSKI ME, Ihms EA, Bigelow K, Kubler A, et al
    Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction.
    J Infect Dis. 2018 Mar 15. pii: 4936447. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
42. MURRAY LW, Satti I, Meyerowitz J, Jones M, et al
    Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.
    J Infect Dis. 2018 Mar 13. pii: 4932783. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    February 2018
43. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    System wide analysis unravels differential regulation and in vivo essentiality of VapBC TA systems from Mycobacterium tuberculosis.
    J Infect Dis. 2018 Feb 24. pii: 4909395. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
44. REECE ST, Vogelzang A, Tornack J, Bauer W, et al
    Mycobacterium tuberculosis-Infected Hematopoietic Stem and Progenitor Cells Unable to Express Inducible Nitric Oxide Synthase Propagate Tuberculosis in Mice.
    J Infect Dis. 2018 Feb 17. pii: 4869967. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
45. CHUNG YT, Pasquinelli V, Jurado JO, Wang X, et al
    Elevated cyclic AMP Inhibits Mycobacterium tuberculosis-stimulated T cell IFN-gamma Secretion through type I Protein Kinase A.
    J Infect Dis. 2018 Feb 8. pii: 4845549. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
46. KURODA MJ, Sugimoto C, Cai Y, Merino KM, et al
    High Turnover of Tissue Macrophages Contributes to Tuberculosis Reactivation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    J Infect Dis. 2018 Feb 8. pii: 4843840. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
47. KHAN N, Divangahi M
    Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.
    J Infect Dis. 2018 Feb 8. pii: 4843841. doi: 10.1093.
    PubMed     Text format    
    
    
    January 2018
48. PAIDIPALLY P, Tripathi D, Van A, Radhakrishnan RK, et al
    IL-21 regulates NK cell responses during Mycobacterium tuberculosis infection.
    J Infect Dis. 2018 Jan 30. pii: 4829454. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
49. HU Z, Zhao HM, Li CL, Liu XH, et al
    The role of KLRG1 in human CD4+ T cell immunity against tuberculosis.
    J Infect Dis. 2018 Jan 24. pii: 4823593. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
50. THOMPSON EG, Shankar S, Gideon HP, Braun J, et al
    Blood RNA signatures prospectively discriminate controllers from progressors early after low-dose M. tuberculosis infection of cynomolgus macaques.
    J Infect Dis. 2018 Jan 8. pii: 4792952. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2017
51. ZHENG R, Liu H, Zhou Y, Yan D, et al
    Notch4 Negatively Regulates the Inflammatory Response to Mycobacterium tuberculosis Infection by Inhibiting TAK1 Activation.
    J Infect Dis. 2017 Dec 8. pii: 4712145. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    November 2017
52. GARFIN C, Mantala M, Yadav R, Hanson CL, et al
    Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
53. HANSON C, Osberg M, Brown J, Durham G, et al
    Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
54. HANSON CL, Osberg M, Brown J, Durham G, et al
    Conducting Patient-Pathway Analysis to Inform Programming of Tuberculosis Services: Methods.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
55. MASINI E, Hanson C, Ogoro J, Brown J, et al
    Using Patient-Pathway Analysis to Inform a Differentiated Program Response to Tuberculosis: The Case of Kenya.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
56. FATIMA R, Haq MU, Yaqoob A, Mahmood N, et al
    Delivering Patient-Centered Care in a Fragile State: Using Patient-Pathway Analysis to Understand Tuberculosis-Related Care Seeking in Pakistan.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
57. SURYA A, Setyaningsih B, Suryani Nasution H, Gita Parwati C, et al
    Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public-Private Collaboration.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
58. FEKADU L, Hanson C, Osberg M, Makayova J, et al
    Increasing Access to Tuberculosis Services in Ethiopia: Findings From a Patient-Pathway Analysis.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
59. SISMANIDIS C, Shete PB, Lienhardt C, Floyd K, et al
    Harnessing the Power of Data to Guide Local Action and End Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
    
60. REID MJA, Goosby E
    Patient-Centered Tuberculosis Programs Are Necessary to End the Epidemic.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
    
61. CHIN DP, Hanson CL
    Finding the Missing Tuberculosis Patients.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
    
62. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
    The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
63. CHURCHYARD G, Kim P, Shah NS, Rustomjee R, et al
    What We Know About Tuberculosis Transmission: An Overview.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
64. TURNER RD, Chiu C, Churchyard GJ, Esmail H, et al
    Tuberculosis Infectiousness and Host Susceptibility.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
65. MATHEMA B, Andrews JR, Cohen T, Borgdorff MW, et al
    Drivers of Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
66. AULD SC, Kasmar AG, Dowdy DW, Mathema B, et al
    Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
67. DOWDY DW, Grant AD, Dheda K, Nardell E, et al
    Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available
    
    
    
68. SHAH NS, Kim P, Kana BD, Rustomjee R, et al
    Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format    
    
    
    
69. SALVATORE PP, Proano A, Kendall EA, Gilman RH, et al
    Linking individual natural history to population outcomes in tuberculosis.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    October 2017
70. AGORO R, Benmerzoug S, Rose S, Bouyer M, et al
    An Iron-Rich Diet Decreases the Mycobacterial Burden and Correlates With Hepcidin Upregulation, Lower Levels of Proinflammatory Mediators, and Increased T-Cell Recruitment in a Model of Mycobacterium bovis Bacille Calmette-Guerin Infection.
    J Infect Dis. 2017;216:907-918.
    PubMed     Text format     Abstract available
    
    
    
71. BUNJUN R, Riou C, Soares AP, Thawer N, et al
    Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    September 2017
72. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    PubMed     Text format     Abstract available
    
    
    August 2017
73. SINGH V, Prakhar P, Rajmani RS, Mahadik K, et al
    Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival.
    J Infect Dis. 2017;216:477-488.
    PubMed     Text format     Abstract available
    
    
    June 2017
74. FOLKVARDSEN DB, Norman A, Andersen AB, Rasmussen EM, et al
    Genomic epidemiology of a major Mycobacterium tuberculosis outbreak: Retrospective cohort study in a low incidence setting using sparse time-series sampling.
    J Infect Dis. 2017 Jun 28. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
75. GUPTA S, Cheung L, Pokkali S, Winglee K, et al
    Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
    J Infect Dis. 2017;215:1883-1887.
    PubMed     Text format     Abstract available
    
    
    May 2017
76. YAO Y, Lai R, Afkhami S, Haddadi S, et al
    A novel virus-vectored respiratory mucosal vaccine enhances anti-tuberculosis immunity in a humanized model system.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
77. ANTHONY RM
    Sputum microscopy and tuberculosis infectiousness.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    
    
    
    
78. DATTA S, Sherman JM, Tovar MA, Bravard MA, et al
    Sputum microscopy with fluorescein diacetate predicts tuberculosis infectiousness.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    April 2017
79. THUONG NTT, Heemskerk D, Tram TTB, Thao LTP, et al
    Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2017
80. OEHLERS SH, Cronan MR, Beerman RW, Johnson MG, et al
    Infection-Induced Vascular Permeability Aids Mycobacterial Growth.
    J Infect Dis. 2017;215:813-817.
    PubMed     Text format     Abstract available
    
    
    February 2017
81. HALLIDAY A, Whitworth H, Hermagild Kottoor S, Niazi U, et al
    Stratification of latent tuberculosis infection by cellular immune profiling.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
82. SHEN H, Gu J, Xiao H, Liang S, et al
    Selective Destruction of Interleukin 23-Induced Expansion of a Major Antigen-Specific gammadelta T-Cell Subset in Patients With Tuberculosis.
    J Infect Dis. 2017;215:420-430.
    PubMed     Text format     Abstract available
    
    
    January 2017
83. CLARK S, Lanni F, Marinova D, Rayner E, et al
    Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    J Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
84. JANSSEN S, Schutz C, Ward AM, Huson MA, et al
    Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.
    J Infect Dis. 2017;215:247-258.
    PubMed     Text format     Abstract available
    
    
    December 2016
85. MARAIS S, Lai RP, Wilkinson KA, Meintjes G, et al
    Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
86. JEYANATHAN M, Damjanovic D, Yao Y, Bramson J, et al
    Induction of an immune protective T cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in man.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
87. MARTINEZ N, Ketheesan N, West K, Vallerskog T, et al
    Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages from Diabetic Mice.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
88. SINGH DK, Dwivedi VP, Ranganathan A, Bishai WR, et al
    Blockade of the Kv1.3 K+ channel enhances BCG vaccine efficacy by expanding central memory T lymphocytes.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
89. CANADAY DH, Toossi Z
    Granulomatous responses in HIV/TB co-infection.
    J Infect Dis. 2016.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: